Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: Randomization by individual versus household

Biometrics

Volumn 55, Issue 3, 1999, Pages 792-798

  Datta, Susmita ^a,b   Halloran, M Elizabeth ^a   Longini, Ira M ^a  

^a EMORY UNIVERSITY   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Clinical trials; Vaccine; Vaccine efficacy

Indexed keywords

EFFICIENCY; RANDOM PROCESSES;

CLINICAL TRIAL; RANDOMISATION; TRANSMISSION PROBABILITIES; VACCINE EFFICACIES;

VACCINES;

ARTICLE; DRUG EFFICACY; INFECTION SENSITIVITY; RANDOMIZATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; VACCINATION;

EID: 0032886393     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0006-341X.1999.00792.x     Document Type: Article

References (26)

1. Agresti, A. (1990). Categorical Data Analysis. New York: John Wiley and Sons.
2. Bailey, N. T. J. (1957). The Mathematical Theory of Epidemics. London: Griffin.
3. Datta, S., Halloran, M., and Longini, I. (1998). Augmented HIV vaccine trial designs for estimating reduction in infectiousness and protective efficacy. Statistics in Medicine 17, 185-200.
4. Donner, A. and Klar, N. (1996). Statistical considerations in the design and analysis of community intervention trials. Journal of Clinical Epidemiology 49, 435-439.
5. Duerr, A., Xai, Z., Nagachinta, T., Toanabutra, S., Tansuhaj, A., and Neslon, K. (1994). Probability of male-to-female HIV transmission among married couples in Chaing Mai, Thailand. In Xth International Conference on AIDS, Yokohama. Abstract 105C.
6. Dunson, D. and Halloran, M. (1996). Estimating transmission blocking efficacy of malaria vaccines. Technical Report 96-16, Department of Biostatistics, Emory University, Atlanta, Georgia.
7. Fine, P., Clarkson, J., and Miller, E. (1988). The efficacy of pertussis vaccines under conditions of household exposure: Further analysis of the 1978-80 PHLS-ERL study in 21 area health authorities in England. International Journal of Epidemiology 17, 635-642.
8. Fox, J., Hall, C., and Elveback, L. (1970). Epidemiology: Man and Disease. New York: MacMillan.
9. Halloran, M., Longini, I., and Struchiner, C. (1996). Estimability and interpretation of vaccine efficacy using frailty mixing models. American Journal of Epidemiology 144, 83-97.
10. Halloran, M., Struchiner, C., and Longini, I. (1997). Study designs for different efficacy and effectiveness aspects of vaccination. American Journal of Epidemiology 146, 789-803.
11. Hayes, R., Mosha, F., Nicoll, A., Grosskurth, H., Newell, J., Todd, J., Killewo, J., Rugemalila, J., and Mabey, D. (1995). A community trial of the impact of improved sexually transmitted disease treatment on HIV epidemic in rural Tanzania: 1. Design. AIDS 9, 919-926.
12. Kendrick, P. and Eldering, G. (1939). A study in active immunization against pertussis. American Journal of Hygine, Section B 38, 133.
13. Kim-Farley, R., Bart, S., Stetler, H., Orenstein, W., Bart, K., Sullivan, K., Halpin, T., and Sirotkin, B. (1985). Clinical mumps vaccine efficacy. American Journal of Epidemiology 121, 593-597.
14. Koepsell, T., Wagner, E., Cheadle, A., Patrick, D., Martin, D., Diehr, P., Perrin, E., Kristal, A., Allan-Andrilla, C., and Dey, C. (1992). Selected methodological issues in evaluating community-based health promotion and disease prevention programs. Annual Reviews of Public Health 13, 31-57.
15. Kolczak, M. (1995). Assumptions and variance estimates in evaluating vaccine efficacy using the household secondary attack rate. Ph.D. thesis, Emory University, Atlanta, Georgia.
16. Koopman, J. and Little, R. (1995). Assessing HIV vaccine effects. American Journal of Epidemiology 142, 1113-1120.
17. Longini, I. and Halloran, M. (1996). A frailty mixture model for estimating vaccine efficacy. Applied Statistics 45, 165-173.
18. Longini, I. and Koopman, J. (1982). Household and community transmission parameters from final distributions of infections in households. Biometrics 38, 115-126.
19. Longini, I., Koopman, J., Haber, M., and Cotsonis, G. (1988). Statistical inference for infectious diseases: Risk-specific household and community transmission parameters. American Journal of Epidemiology 128, 845-859.
20. Longini, I., Halloran, M., Haber, M., and Chen, R. (1993). Measuring vaccine efficacy from epidemics of acute infectious agents. Statistics in Medicine 12, 249-263.
21. Longini, I., Datta, S., and Halloran, M. (1996). Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirus 13, 440-447.
22. Magder, L. and Brookmeyer, R. (1993). Analysis of infectious disease data from partners studies with unknown source of infection. Biometrics 49, 1110-1116.
23. Mastro, T. and de Vincenzi, I. (1996). Probabilities of sexual HIV-1 transmission. AIDS 10(Suppl. A), S75-S82.
24. Orenstein, W., Bernier, R., and Hinman, A. (1988). Assessing vaccine efficacy in the field: Further observations. Epidemiologic Reviews 10, 212-241.
25. Ross, A. (1962). Modification of chicken pox in family contacts by administration of gamma globulin. New England Journal of Medicine 267, 369-376.
26. Wolfram, S. (1991). Mathematica. Redwood City, California: Addison-Wesley.